Starpharma (SPHRY) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free SPHRY Stock Alerts $0.92 +0.07 (+8.24%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartShort InterestStock AnalysisChartShort Interest Starpharma Short Interest DataCurrent Short Volume2,700 sharesPrevious Short Volume2,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$2,322.00Short Interest Ratio / Days to Cover1.5Last Record DateApril 15, 2024Outstanding Shares41,200,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume7,148 sharesAverage Trading Volume732 sharesToday's Volume Vs. Average976% Short Selling Starpharma ? Sign up to receive the latest short interest report for Starpharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSPHRY Short Interest Over TimeSPHRY Days to Cover Over TimeSPHRY Percentage of Float Shorted Over Time Ad Behind the MarketsThe World's First "$20 Trillion Drug?"One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!Get the name of the stock here >>> Starpharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,700 shares $2,322.00 No ChangeN/A1.5 $0.86 3/31/20242,700 shares $2,214.00 -70.0%N/A1.9 $0.82 3/15/20249,000 shares $7,830.00 +12.5%N/A0.7 $0.87 2/29/20248,000 shares $7,601.60 +9.6%N/A2.7 $0.95 2/15/20247,300 shares $6,935.00 -7.6%N/A3.7 $0.95 1/15/20248,200 shares $8,446.00 -4.7%N/A10.2 $1.03 Get the Latest News and Ratings for SPHRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Starpharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20238,600 shares $10,698.40 +45.8%N/A2.4 $1.24 12/15/20235,900 shares $5,510.01 +78.8%N/A1.2 $0.93 11/30/20233,300 shares $3,234.00 -37.7%N/A0.9 $0.98 11/15/20235,300 shares $0.00 No ChangeN/A13.3 $0.00 10/31/20235,300 shares $4,858.51 +140.9%N/A4.1 $0.92 10/15/20232,200 shares $2,024.00 -50.0%N/A1.2 $0.92 9/30/20234,400 shares $4,774.00 +10.0%N/A2.3 $1.09 9/15/20234,000 shares $3,580.40 -16.7%N/A0.5 $0.90 8/31/20234,800 shares $4,656.00 +84.6%N/A0.9 $0.97 8/15/20232,600 shares $2,834.00 No ChangeN/A0.5 $1.09 6/15/2023200 shares $520.00 No ChangeN/A0.4 $2.60 5/31/2023200 shares $580.00 No ChangeN/A2 $2.90 5/15/2023200 shares $608.00 +100.0%N/A0.2 $3.04 4/30/2023100 shares $325.00 No ChangeN/A0.1 $3.25 4/15/2023100 shares $307.00 No ChangeN/A0.1 $3.07 3/31/2023100 shares $318.00 No ChangeN/A0.1 $3.18 3/15/2023100 shares $306.00 No ChangeN/A0.1 $3.06 2/28/2023100 shares $350.00 No ChangeN/A0.3 $3.50 2/15/2023100 shares $387.00 -50.0%N/A0.5 $3.87 1/31/2023200 shares $924.00 -33.3%N/A0.4 $4.62 1/15/2023300 shares $1,381.68 No ChangeN/A0.1 $4.61 12/30/2022300 shares $1,092.00 No ChangeN/A0.1 $3.64 12/15/2022300 shares $1,035.00 -40.0%N/A0.2 $3.45 11/30/2022500 shares $1,775.00 -16.7%N/A0.6 $3.55 11/15/2022600 shares $2,310.00 No ChangeN/A0.5 $3.85 10/31/2022600 shares $2,082.00 -45.5%N/A0.5 $3.47 10/15/20221,100 shares $4,543.00 No ChangeN/A0.3 $4.13 9/15/2022100 shares $405.00 No ChangeN/A0 $4.05 5/15/2022500 shares $2,700.00 No ChangeN/A0.4 $5.40 11/30/2021700 shares $5,285.00 -46.2%N/A0.2 $7.55 11/15/20211,300 shares $10,010.00 -51.9%N/A0.4 $7.70 10/29/20212,700 shares $21,303.00 +8.0%N/A0.6 $7.89 10/15/20212,500 shares $22,125.00 +92.3%N/A2.3 $8.85 9/30/20211,300 shares $11,973.13 -31.6%N/A0.6 $9.21Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. SPHRY Short Interest - Frequently Asked Questions What is Starpharma's current short interest? Short interest is the volume of Starpharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,700 shares of SPHRY short. Learn More on Starpharma's current short interest. What is a good short interest ratio for Starpharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPHRY shares currently have a short interest ratio of 2.0. Learn More on Starpharma's short interest ratio. How does Starpharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Starpharma: bioAffinity Technologies, Inc. (4.35%), United-Guardian, Inc. (0.04%), Cyclo Therapeutics, Inc. (0.47%), BriaCell Therapeutics Corp. (4.88%), Brainstorm Cell Therapeutics Inc. (2.91%), Pixie Dust Technologies, Inc. (0.02%), Spectral AI, Inc. (1.90%), DarioHealth Corp. (4.65%), LENSAR, Inc. (0.73%), Science 37 Holdings, Inc. (0.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Starpharma stock? Short selling SPHRY is an investing strategy that aims to generate trading profit from Starpharma as its price is falling. SPHRY shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Starpharma? A short squeeze for Starpharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHRY, which in turn drives the price of the stock up even further. How often is Starpharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHRY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BIAF Short Interest UG Short Interest CYTH Short Interest BCTX Short Interest BCLI Short Interest PXDT Short Interest MDAI Short Interest DRIO Short Interest LNSR Short Interest SNCE Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SPHRY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press